The Enterprise Value as of December 2025 (TTM) for Cara Therapeutics, Inc. (0HTC.L) is 20.18M

According to Cara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.18M. This represents a change of -86.26% compared to the average of 146.92M of the last 4 quarters.

Cara Therapeutics, Inc. (0HTC.L) Historical Enterprise Value (quarterly & annually)

How has 0HTC.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Cara Therapeutics, Inc. over the last ten years is 8.24M. The current 20.18M Enterprise Value has changed 24.41% with respect to the historical average. Over the past ten years (40 quarters), 0HTC.L's Enterprise Value was at its highest in in the September 2025 quarter at 344.23M. The Enterprise Value was at its lowest in in the September 2023 quarter at -48588919.70.

Cara Therapeutics, Inc. (0HTC.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cara Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cara Therapeutics, Inc. (0HTC.L) Average Enterprise Value

How has 0HTC.L Enterprise Value performed in the past?

The current Enterprise Value of Cara Therapeutics, Inc. (0HTC.L) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cara Therapeutics, Inc. (0HTC.L) Enterprise Value vs. Peers

How is 0HTC.L’s Enterprise Value compared to its peers?

Cara Therapeutics, Inc.’s Enterprise Value is greater than VivoSim Labs, Inc. (-2547643.00), less than Imunon, Inc. (1.11B), less than Palatin Technologies, Inc. (707.13M), greater than Unity Biotechnology, Inc. (18.05M), greater than Endo International plc (-939048027.00), greater than DMK Pharmaceuticals Corporation (-737792.00), less than bluebird bio, Inc. (158.07M), greater than Zynerba Pharmaceuticals, Inc. (19.81M), less than Accelerate Diagnostics, Inc. (52.34M), less than Invitae Corporation (1.50B),

Build a custom stock screener for Cara Therapeutics, Inc. (0HTC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cara Therapeutics, Inc. (0HTC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.